AANAT | Aralkylamine N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| ![](/images/50784/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50784/115756_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| ![](/images/40470/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40470/87248_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ACVR2B | Activin A receptor, type IIB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| ![](/images/25115/ihc_selected_60x60.jpg) | ![](/images/25115/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/25115/57042_B_8_1_rna_selected_60x60.jpg) | Mixed |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/46467/ihc_cell_selected_60x60.jpg) | ![](/images/46467/104620_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
ADM | Adrenomedullin | Cancer-related genes Plasma proteins Predicted secreted proteins
| ![](/images/16075/ihc_selected_60x60.jpg) | ![](/images/31806/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16075/35861_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/57688/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/57688/ihc_cell_selected_60x60.jpg) | ![](/images/57688/133031_B_5_5_rna_selected_60x60.jpg) | Tissue enhanced |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted membrane proteins
| ![](/images/40332/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40332/88014_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| ![](/images/19544/ihc_selected_60x60.jpg) | ![](/images/19544/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19544/45568_B_2_3_rna_selected_60x60.jpg) | Expressed in all |
AGRP | Agouti related protein homolog (mouse) | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/41017/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41017/87145_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1524/4371_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins
| | ![](/images/4308/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53891/134685_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/10694/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10694/26073_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
ANGPTL4 | Angiopoietin-like 4 | Plasma proteins Predicted secreted proteins
| ![](/images/33770/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33770/152718_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
ANKRD26 | Ankyrin repeat domain 26 | | ![](/images/40654/ihc_selected_60x60.jpg) | ![](/images/40654/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40654/87553_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
ANKRD62 | Ankyrin repeat domain 62 | | ![](/images/59835/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/59835/136509_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | ![](/images/11271/29845_B_1_8_rna_selected_60x60.jpg) | Expressed in all |
AP3S1 | Adaptor-related protein complex 3, sigma 1 subunit | | ![](/images/49270/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49270/114478_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8363/20779_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
APRT | Adenine phosphoribosyltransferase | Disease related genes Enzymes Plasma proteins Potential drug targets
| ![](/images/26681/ihc_selected_60x60.jpg) | | | ![](/images/26681/55447_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted membrane proteins Transporters
| ![](/images/22144/ihc_selected_60x60.jpg) | ![](/images/22144/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22144/49153_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
ATP6V0A2 | ATPase, H+ transporting, lysosomal V0 subunit a2 | Disease related genes Plasma proteins Predicted membrane proteins
| ![](/images/44279/ihc_selected_60x60.jpg) | ![](/images/44279/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/44279/99306_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images/18029/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/18029/40901_B_8_2_rna_selected_60x60.jpg) | Group enriched |
ATP6V0B | ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b | Predicted membrane proteins
| ![](/images/44281/ihc_selected_60x60.jpg) | ![](/images/44281/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/44281/99438_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
ATP6V0D1 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 | Plasma proteins Transporters
| ![](/images/16938/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16938/37330_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | | | ![](/images_static/na_center.gif) | ![](/images/55327/ihc_cell_selected_60x60.jpg) | ![](/images/55327/131791_A_8_7_rna_selected_60x60.jpg) | Tissue enriched |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Enzymes Plasma proteins Transporters
| | | ![](/images/6910/ihc_cell_selected_60x60.jpg) | ![](/images/6910/16208_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31847/111072_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | FDA approved drug targets Transporters
| ![](/images/8147/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/8147/23792_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
ATP6V1C1 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 | Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/23943/53698_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
ATP6V1C2 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 | Transporters
| ![](/images/34734/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34734/75429_A_3_1_rna_selected_60x60.jpg) | Group enriched |
ATP6V1D | ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D | | ![](/images/31515/ihc_selected_60x60.jpg) | ![](/images/57316/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31515/120211_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | Plasma proteins Transporters
| | ![](/images/29196/if_selected_60x60.jpg) | ![](/images/29196/ihc_cell_selected_60x60.jpg) | ![](/images/29196/103294_B_6_4_rna_selected_60x60.jpg) | Expressed in all |
ATP6V1E2 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2 | | ![](/images/52784/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/52784/122656_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
ATP6V1F | ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F | Transporters
| | ![](/images/48700/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/62011/138554_A_9_8_rna_selected_60x60.jpg) | Expressed in all |
ATP6V1G1 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 | Plasma proteins Transporters
| ![](/images/4615/ihc_selected_60x60.jpg) | | ![](/images/4615/ihc_cell_selected_60x60.jpg) | ![](/images/4615/19874_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4616/142174_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28701/146530_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
ATP6V1H | ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H | Transporters
| | ![](/images/23421/if_selected_60x60.jpg) | ![](/images/9532/ihc_cell_selected_60x60.jpg) | ![](/images/23421/51117_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BAIAP2L1 | BAI1-associated protein 2-like 1 | | | | | ![](/images/29503/61555_B_8_1_rna_selected_60x60.jpg) | Mixed |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | ![](/images/443/1114_B_2_5_rna_selected_60x60.jpg) | Mixed |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/30947/72611_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BMP8A | Bone morphogenetic protein 8a | Predicted secreted proteins
| ![](/images/44883/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44883/115546_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
BSCL2 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42394/91857_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
CAB39 | Calcium binding protein 39 | Plasma proteins
| | ![](/images/37112/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37112/74921_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
CAB39L | Calcium binding protein 39-like | Plasma proteins
| ![](/images/45954/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45954/123578_B_3_5_rna_selected_60x60.jpg) | Expressed in all |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64258/144292_A_4_3_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1D | Calcium channel, voltage-dependent, L type, alpha 1D subunit | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/20215/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20215/47849_B_7_3_rna_selected_60x60.jpg) | Mixed |
CACNA2D2 | Calcium channel, voltage-dependent, alpha 2/delta subunit 2 | FDA approved drug targets Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34771/141854_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
CAMK2G | Calcium/calmodulin-dependent protein kinase II gamma | Enzymes Plasma proteins Predicted membrane proteins
| ![](/images/51783/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51783/120543_A_4_6_rna_selected_60x60.jpg) | Expressed in all |
CARTPT | CART prepropeptide | FDA approved drug targets Predicted secreted proteins
| ![](/images/46278/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46278/103746_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |